Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Oct 21, 2024

BUY
$3.08 - $8.73 $376,040 - $1.07 Million
122,091 New
122,091 $376,000
Q1 2023

May 03, 2023

BUY
$3.08 - $8.73 $176,163 - $499,321
57,196 Added 88.14%
122,091 $376,000
Q4 2022

Feb 13, 2023

BUY
$3.33 - $6.38 $216,100 - $414,030
64,895 New
64,895 $343,000

Others Institutions Holding PSTX

About Poseida Therapeutics, Inc.


  • Ticker PSTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 85,775,600
  • Market Cap $810M
  • Description
  • Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...
More about PSTX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.